Who is sponsoring CANNA-TICS?

CANNA-TICS is sponsored by Hannover Medical School.

What condition does CANNA-TICS study?

CANNA-TICS studies Tourette Syndrome, Tic Disorders.

What drugs are being tested in CANNA-TICS?

Interventions: nabiximols, placebo.

What is the status of CANNA-TICS?

CANNA-TICS is currently COMPLETED.

Last reviewed 2020-12-10 · How we verify

CANNAbinoids in the Treatment of TICS (CANNA-TICS)

NCT03087201 PHASE3 COMPLETED

This is a multicentre, randomized, double-blind, placebo controlled, parallel-group, phase IIIb trial. Patients (≥18 years) with chronic tic disorders and Tourette syndrome will be recruited. The objective of the trial is to demonstrate that treatment with the cannabis extract nabiximols is superior to placebo in reducing tics and comorbidities in patients with Tourette syndrome and chronic tic disorders.

Details

Lead sponsor	Hannover Medical School
Phase	PHASE3
Status	COMPLETED
Enrolment	98
Start date	Thu Apr 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Nov 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Tourette Syndrome
Tic Disorders

Interventions

nabiximols
placebo

Countries

Germany